Formycon reports nine-month results for 2024 and continues growth trajectory with further operational success Excellent third quarter with product approvals for FYB202 in the key markets USA and ...
In a report released today, Glen Santangelo from Jefferies maintained a Buy rating on Doximity (DOCS – Research Report), with a price target of ...
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Skeletal Dysplasia Market by Type, Treatment, End User - Global Forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback